Zymeworks Inc. Common Stock (United States) is listed on the Nasdaq and has a market capitalization of $1.78 Billion, with shareholders equity totaling $163.59 Billions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Zymeworks Inc. Common Stock reported $51.24 Millions in revenue, generating net income of $-84.10 Billions.
Key financial metrics include a P/E ratio of -0.02, a price-to-book (P/B) ratio of 0.01, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ZYME.